Rocketing to a price of $281.23 during today's morning trading session, shares of Cigna are still -29.12% below their average target price of $396.77. Could there be more upside potential for the stock? Analysts are giving CI an average rating of buy and target prices ranging from $344.78 to $438.0 dollars per share.
The market seems to share this rosy outlook, since Cigna has a short interest of only 1.1%. This represents the percentage of the share float that is being shorted, and each short position stands for an investor's expectation that the price of the stock will go down in the future.
When a stock is sold short, it means an investor has borrowed shares of the stock from their broker, and then sold them at the going market price. The investor hopes for the price to decline, so that they might buy those shares back at a lower price in the future. Once they do, they can return the borrowed shares to their broker, and keep the profit they made on the transaction.
One way to get an idea of the market sentiment on a stock is to check its rate of institutional ownership. In the case of Cigna, institutional investors own 89.6% of the shares. This would indicate a positive sentiment towards the stock among institutions. What does this really tell us?
Institutional investors such as hedge funds, investment firms, and wealth managers devote significant resources to identifying good investments. If they have decided to invest in CI, it probably means they believe it is a solid investment choice. But it could also mean they are buying up shares in an effort to acquire the company or get seats on the board of directors. Also bear in mind that institutions are fallible (just maybe not quite as fallible as the average retail investor), so they may simply be wrong when they think they've found a good stock.
In conclusion, we see positive market sentiment regarding Cigna because of an analyst consensus of strong upside potential, a buy rating, a very low short interest, and a significant number of institutional investors. At Market Inference, we believe that any investment decision should be preceded by an in-depth analysis of the company's fundamental values and a comparison with similar stocks.
Here's a snapshot of some important facts to keep in mind about CI:
-
The stock has trailing 12 month earnings per share (EPS) of $10.54
-
Cigna has a trailing 12 month Price to Earnings (P/E) ratio of 26.7 compared to the S&P 500 average of 29.3
-
The company has a Price to Book (P/B) ratio of 1.87 in contrast to the S&P 500's average ratio of 4.74
-
Cigna is a Health Care company, and the sector average P/E and P/B ratios are 26.07 and 3.53 respectively
